Skip to content
value.today

Bioformix Inc.

Formerly Bioformix LLC

Total raised
$29 M
3 rounds on record
Latest round
$7 M
Feb 2015
First round on record
Sep 2011
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Bioformix Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2015$7 MNo. 3$2 to $10 million

Bioformix Inc.: Raise no. 3, Feb 2015

Investors in this round

6 investors had bought by the notice of Feb 19, 2015: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $8 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jeff Uhrig · Executive Officer, Director · President, Chief Executive Officer, Secretary and Treasurer
  • John Habbert · Executive Officer, Director · Assistant Secretary
  • Adam Malofsky · Director
  • Doug Cameron · Director
  • John Trbovich · Director
  • Kieran Drain · Director
  • Robert Pangborn · Director
  • William Lese · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “$2,043,396 worth of previously issued notes converted to stock; $4,578,292 worth issued from fresh cash out of a total cash offering of $6,146,092.”

Signed by Jeff Uhrig, Ceo. Source: SEC Form D, newest notice filed Feb 19, 2015. Read the notice at the SEC.

equity, optionsSEC
May 2013$14 MNo. 2$10 to $50 million

Bioformix Inc.: Raise no. 2, May 2013

Investors in this round

7 investors had bought by the notice of Jan 22, 2014: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$14 M of $15 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Adam Malofsky · Executive Officer, Director · Chief Innovation Officer
  • Bernard Malofsky · Executive Officer · Chief Technology Officer
  • Jeff Uhrig · Executive Officer, Director · President, Chief Executive Officer, Secretary, and Treasurer
  • John Habbert · Executive Officer, Director · Assistant Secretary
  • Doug Cameron · Director
  • John Trbovich · Director
  • Kieran Drain · Director
  • Robert Pangborn · Director
  • William Lese · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jeff Uhrig, President. Source: SEC Form D and 1 amendment, newest notice filed Jan 22, 2014. Read the notice at the SEC.

equity, optionsSEC
Sep 2011$8 MNo. 1$2 to $10 million

Bioformix Inc.: Raise no. 1, Sep 2011

Investors in this round

23 investors had bought by the notice of Jan 13, 2012: 23 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $13 M offered; $5 M still to sell
Smallest investment taken
$5,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Adam Malofsky · Executive Officer, Director
  • Bernard Malofsky · Executive Officer
  • John Habbert · Executive Officer, Director
  • Robert Smith · Executive Officer
  • Doug Cameron · Director
  • John Trbovich · Director
  • Kieran Drain · Director
  • Robert Pangborn · Director
  • William Lese · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Adam Malofsky, President. Source: SEC Form D and 1 amendment, newest notice filed Jan 13, 2012. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Bioformix Inc. chose not to state its revenue in its newest notice of a funding round (Feb 2015).

    SEC Form D · Feb 2015

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Feb 2015

That is all the official record says: Bioformix Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Bioformix Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 23 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Bioformix Inc.
NameRoleNamed in
Jeff UhrigPresident, Chief Executive Officer, Secretary and TreasurerFeb 2015
John HabbertAssistant SecretaryFeb 2015
Adam MalofskyChief Innovation OfficerJan 2014
Bernard MalofskyChief Technology OfficerJan 2014
Robert SmithExecutive officerJan 2012
Adam MalofskyDirectorFeb 2015
Doug CameronDirectorFeb 2015
Jeff UhrigPresident, Chief Executive Officer, Secretary and TreasurerFeb 2015
John HabbertAssistant SecretaryFeb 2015
John TrbovichDirectorFeb 2015
Kieran DrainDirectorFeb 2015
Robert PangbornDirectorFeb 2015
William LeseDirectorFeb 2015